tirzepatide types is a modern injectable medication used for the treatment of Type 2 Diabetes Mellitus. It belongs to a new class of drugs that work on two key hormones (GIP and GLP-1 Tirzepatide for Weight Loss |

They function to reduce glycemia through multiple mechanisms, such as stimulating glucose-dependent insulin secretion from pancreatic cells, suppressing glucagon secretion from pancreatic cells, and delaying gastric emptying

Tirzepatide significantly reduces body weight in obese individuals (source: Lilly website) Eli Lilly is currently testing the effectiveness of tirzepatide for treating different types of obese groups in a number of other Phase 3 clinical trials, which are expected to yield results next year

S1P 1 is also known as EDG-1, S1P 2 as EDG-5, S1P 3 as EDG-3, S1P 4 as EDG-6, and S1P 5 as EDG-8

The whole process took less than a week

Following an initial 72-week primary analysis, with results published in the New England Journal of Medicine in 2022, 2 1032 participants with pre-diabetes remained enrolled in the trial for an additional 104 weeks of treatment